Post-marketing Safety Assessment of CAR T-cell Therapies: Analysis of Individual Case Safety Reports in the VigiBase.
Saved in:
| Title: | Post-marketing Safety Assessment of CAR T-cell Therapies: Analysis of Individual Case Safety Reports in the VigiBase. |
|---|---|
| Authors: | AlRasheed MM; Saudi Food and Drug Authority, 4904 Northern Ring Branch Rd, Hittin Dist, 13513-7148, Riyadh, Saudi Arabia. mmrasheed@sfda.gov.sa., AlHawas SM; Saudi Food and Drug Authority, 4904 Northern Ring Branch Rd, Hittin Dist, 13513-7148, Riyadh, Saudi Arabia., AlOrf NN; Saudi Food and Drug Authority, 4904 Northern Ring Branch Rd, Hittin Dist, 13513-7148, Riyadh, Saudi Arabia., AlFadel NS; Saudi Food and Drug Authority, 4904 Northern Ring Branch Rd, Hittin Dist, 13513-7148, Riyadh, Saudi Arabia., AlHarbi FF; Saudi Food and Drug Authority, 4904 Northern Ring Branch Rd, Hittin Dist, 13513-7148, Riyadh, Saudi Arabia. |
| Source: | Therapeutic innovation & regulatory science [Ther Innov Regul Sci] 2025 Nov; Vol. 59 (6), pp. 1432-1441. Date of Electronic Publication: 2025 Jul 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101597411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2168-4804 (Electronic) Linking ISSN: 21684790 NLM ISO Abbreviation: Ther Innov Regul Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2168-4804 |
|---|---|
| DOI: | 10.1007/s43441-025-00826-7 |
